| 1. |
Rosendaal, F. R. (1999) Venous thrombosis: a multicausal disease. Lancet 353, 1167–1173.
|
| |
| 2. |
Franco, R. F., Reitsma, P. H. (2001) Genetic risk factors of venous thrombosis. Hum Genet 109, 369–384.
|
| |
| 3. |
Bertina, R. M., Koeleman, B. P., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., et al. (1994) Mutation in blood
coagulation factor V associated with resistance to activated protein C. Nature 369, 64–67.
|
| |
| 4. |
Poort, S. R., Rosendaal, F. R., Reitsma, P. H., Bertina, R. M. (1996) A common genetic variation in the ′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous
thrombosis. Blood 88, 3698–3703.
|
| |
| 5. |
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., et al. (1995) A candidate genetic risk
factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111–113.
|
| |
| 6. |
van der Put, N. M. J., Gabreels, F., Stevens, E. M. B., Smeitink, J. A. M., Trijbels, F. J. M., Eskes, T. K. A. B., et al.
(1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube
defects? Am J Hum Genet 62, 1044–1051.
|
| |
| 7. |
Mikkola, H., Syrjala, M., Rasi, V., Vahtera, E., Hamalainen, E., Peltonen, L., Palotie, A. (1994) Deficiency in the A-subunit
of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84, 517–525.
|
| |
| 8. |
Girard, T. J., Eddy, R., Wesselschmidt, R. L., MacPhail, L. A., Likert, K. M., Byers, M. G., et al. (1991) Structure of the
human lipoprotein-associated coagulation inhibitor gene. J Biol Chem 266, 5036–5041.
|
| |
| 9. |
Franco, R. F., Morelli, V., Lourenco, D., Maffei, F. H., Tavella, M. H., Piccinato, C. E., et al. (1999) A second mutation
in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol 105, 556–559.
|
| |
| 10. |
Franco, R. F., Reitsma, P. H., Lourenco, D., Maffei, F. H., Morelli, V., Tavella, M. H., et al. (1999) Factor XIII Val34Leu
is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost 81, 676–679.
|
| |
| 11. |
van Hylckama Vlieg, A., Komanasin, N., Ariens, R. A. S., Poort, S. R., Grant, P. J., Bertina, R. M., Rosendaal, F. R. (2002)
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep vein thrombosis. Br J Haematol 119, 169–175.
|
| |
| 12. |
Kleesiek, K., Schmidt, M., Gotting, C., Brinkmann, T., Prohaska, W. (1998) A first mutation in the human tissue factor pathway
inhibitor gene encoding [P151L]TFPI. Blood 92, 3976–3977.
|
| |
| 13. |
Kleesiek, K., Schmidt, M., Gotting, C., Schwenz, B., Lange, S., Muller-Berghaus, G., et al. (1999) The 536C→T transition in
the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis.
Thromb Haemost 82, 1–5.
|
| |
| 14. |
Evans, G. D., Langdown, J., Brown, K., Baglin, T. P. (2000) The C536T transition in the tissue factor pathway inhibitor gene
is not a common cause of venous thromboembolic disease in the UK population. Thromb Haemost 83, 511.
|
| |
| 15. |
Mullis, K. B., Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155, 335–350.
|
| |
| 16. |
Markoulatos, P., Siafakas, N., Moncany, M. (2002) Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal 16, 47–51.
|
| |
| 17. |
Ugozzoli, L., Wahlqvist, J. M., Ehsani, A., Kaplan, B. E., Wallace, R. B. (1992) Detection of specific alleles by using allele-specific
primer extension followed by capture on solid support. Genet. Anal Tech Appl 9, 107–112.
|
| |
| 18. |
Ye, F., Li, M., Taylor, J. D., Nguyen, Q., Colton, H. M., Casey, W. M., et al. (2001) Fluorescent microsphere-based readout
technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat 17, 305–316.
|
| |
| 19. |
Dunbar, S. A. (2006) Applications of LuminexˆledR xMAP™ technology for rapid, high-throughput multiplexed nucleic acid detection.
Clin Chim Acta 363, 71–82.
|
| |
| 20. |
Bortolin, S., Black, M., Modi, H., Boszko, I., Kobler, D., Fieldhouse, D., et al. (2004) Analytical validation of the Tag-It
high-throughput microsphere-based universal array genotyping platform: application to the multiplex detection of a panel of
thrombophilia-associated single-nucleotide polymorphisms. Clin Chem 50, 2028–2036.
|
| |